[Asia Economy Reporter Hyunseok Yoo] JLKE Inspection is showing strong performance. The growth expectations from the strategic collaboration between JLKE Inspection, a medical analysis solution company based on artificial intelligence, and Intel, a global semiconductor technology leader, appear to have influenced the stock price.
As of 10:33 AM, JLKE Inspection was trading at 4,400 KRW, up 9.73% (390 KRW) compared to the previous trading day.
Since last year, JLKE Inspection has signed two official global partnerships with Intel, including the ‘IoT and Artificial Intelligence (AI) Builder Partnership,’ and has engaged in technical cooperation.
They revealed the results of collaboration between Intel’s computer vision and AI solution development tool 'OpenVINO' technology and JLKE Inspection’s AI medical algorithms. According to materials released by Intel, among the 37 solutions in AIHuB, the AI-based chest X-ray analysis solution and 3D brain MRI analysis solution, developed in cooperation with Intel, improved image analysis speed by approximately 40% in environments without internet access or expensive GPUs.
JLKE Inspection and Intel have established a foundation to operate high-performance AI medical algorithms on general home PCs without expensive GPUs.
Regarding JLKE Inspection’s chest X-ray analysis solution, which has gained attention due to the spread of the novel coronavirus infection (COVID-19), they optimized it for Intel’s mini PC and unveiled real-time X-ray on-site analysis and mobile operation technology integrated into vehicle-type X-ray equipment. It can also be used for quantitative analysis to separate the movement paths of COVID-19 patients and prioritize diagnosis and treatment.
The brain aging analysis solution has been commercialized since March at Seoul National University Gangnam Health Screening Center, where actual examinees can receive the service. JLKE Inspection, together with Intel, optimized a self-designed neural network to reduce the process time from 6 hours in the existing solution to under 15 minutes without a GPU.
Intel expects this technology to effectively enable medical professionals to see more patients within the given time in clinical settings.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
